From Patents to Patients: Reinventing Arterial Treatment

What happens when one of the toughest challenges in vascular medicine—severe arterial calcification—meets breakthrough engineering?

In this episode of Med Tech Gurus, we sit down with Dr. Robert Chisena, Co-Founder and CTO of Amplitude Vascular Systems (AVS). With a PhD in mechanical engineering and a portfolio of five patents, Robert has dedicated his career to tackling one of the most stubborn barriers in cardiovascular health: hardened arterial blockages that resist traditional interventions.

From the labs at the University of Michigan to the founding of AVS, Robert shares how he and his team are developing a next-generation intravascular lithotripsy platform designed to fracture calcium safely and effectively—combining the familiarity of angioplasty with the power of shockwave technology. Along the way, he offers lessons on building IP-rich startups, fostering innovation cultures, securing clinical adoption, and navigating the high-stakes path from spinout to commercialization

Whether you're an engineer, entrepreneur, or investor in medtech, this conversation shines a light on the strategies, setbacks, and breakthroughs required to transform a complex clinical challenge into a scalable, life-saving solution.